Comments on: Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial

Comments on: Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial – The Lancet https://yeoys.com/blog/health-medical-news/immunogenicity-and-safety-of-a-recombinant-adenovirus-type-5-vectored-covid-19-vaccine-in-healthy-adults-aged-18-years-or-older-a-randomised-double-blind-placebo-controlled-phase-2-trial-the-lan/ your emotion on your shirt Mon, 20 Jul 2020 19:27:59 +0000 hourly 1 https://wordpress.org/?v=5.3.18